• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

METTL3被环状RNA circMETTL3/miR-34c-3p信号通路抑制,并限制三阴性乳腺癌的肿瘤生长和转移。

METTL3 Is Suppressed by Circular RNA circMETTL3/miR-34c-3p Signaling and Limits the Tumor Growth and Metastasis in Triple Negative Breast Cancer.

作者信息

Ruan Han-Guang, Gu Wen-Chao, Xia Wen, Gong Yan, Zhou Xue-Liang, Chen Wen-Yan, Xiong Juan

机构信息

Department of Breast Oncology, The Third Hospital of Nanchang, Nanchang, China.

Department of Diagnostic of Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

出版信息

Front Oncol. 2021 Dec 22;11:778132. doi: 10.3389/fonc.2021.778132. eCollection 2021.

DOI:10.3389/fonc.2021.778132
PMID:35004298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8727604/
Abstract

Despite N6-methyladenosine (mA) is functionally important in various biological processes, its role in the underlying regulatory mechanism in TNBC are lacking. In this study, we investigate the pathological role and the underlying mechanism of the mA methylated RNA level and its major methyltransferase METTL3 in the TNBC progression. We found that the mA methylated RNA was dramatically decreased in TNBC tissues and cell lines. Functionally, we demonstrated that METTL3 inhibits the proliferation, migration, and invasion ability of TNBC cells. Moreover, we found METTL3 is repressed by miR-34c-3p in TNBC cells. On the mechanism, we found that circMETTL3 could act as a sponge for miR-34c-3p and inhibits cell proliferation, invasion, tumor growth and metastasis by up-regulating the expression of miR-34c-3p target gene METTL3. In conclusion, our study demonstrates the functional importance and regulatory mechanism of METTL3 in suppressing the tumor growth of TNBC.

摘要

尽管N6-甲基腺嘌呤(mA)在各种生物学过程中具有重要功能,但其在三阴性乳腺癌(TNBC)潜在调控机制中的作用仍不清楚。在本研究中,我们探究了mA甲基化RNA水平及其主要甲基转移酶METTL3在TNBC进展中的病理作用及潜在机制。我们发现,TNBC组织和细胞系中mA甲基化RNA显著降低。在功能上,我们证明METTL3抑制TNBC细胞的增殖、迁移和侵袭能力。此外,我们发现TNBC细胞中METTL3受miR-34c-3p抑制。在机制方面,我们发现环状METTL3(circMETTL3)可作为miR-34c-3p的海绵,通过上调miR-34c-3p靶基因METTL3的表达来抑制细胞增殖、侵袭、肿瘤生长和转移。总之,我们的研究证明了METTL3在抑制TNBC肿瘤生长中的功能重要性及调控机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/543376a8e433/fonc-11-778132-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/368c64d0f6e4/fonc-11-778132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/68525fd81ad4/fonc-11-778132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/0277feef5ae8/fonc-11-778132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/8a4490e35c30/fonc-11-778132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/2cd600ab79eb/fonc-11-778132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/036583b9c657/fonc-11-778132-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/543376a8e433/fonc-11-778132-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/368c64d0f6e4/fonc-11-778132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/68525fd81ad4/fonc-11-778132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/0277feef5ae8/fonc-11-778132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/8a4490e35c30/fonc-11-778132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/2cd600ab79eb/fonc-11-778132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/036583b9c657/fonc-11-778132-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1736/8727604/543376a8e433/fonc-11-778132-g007.jpg

相似文献

1
METTL3 Is Suppressed by Circular RNA circMETTL3/miR-34c-3p Signaling and Limits the Tumor Growth and Metastasis in Triple Negative Breast Cancer.METTL3被环状RNA circMETTL3/miR-34c-3p信号通路抑制,并限制三阴性乳腺癌的肿瘤生长和转移。
Front Oncol. 2021 Dec 22;11:778132. doi: 10.3389/fonc.2021.778132. eCollection 2021.
2
CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression.环状 RNA 甲基转移酶样 3 (METTL3)在 m6A 依赖性方式上调,促进乳腺癌进展。
Int J Biol Sci. 2021 Mar 15;17(5):1178-1190. doi: 10.7150/ijbs.57783. eCollection 2021.
3
Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.miR-34c-3p通过调节三阴性乳腺癌细胞中的MAP3K2信号传导对癌进展和上皮-间质转化的调控
Biochem Biophys Res Commun. 2017 Jan 29;483(1):10-16. doi: 10.1016/j.bbrc.2017.01.023. Epub 2017 Jan 7.
4
Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.甲基转移酶样蛋白 3(METTL3)介导的 N6-甲基腺苷(m6A)修饰促进微 RNA-25-3p 的成熟,从而促进胃肠道间质瘤(GISTs)的进展。
Genes Genomics. 2022 Dec;44(12):1519-1530. doi: 10.1007/s13258-022-01301-5. Epub 2022 Aug 30.
5
WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis.WFDC21P通过WFDC21P/miR-628/SMAD3轴促进三阴性乳腺癌的增殖和迁移。
Front Oncol. 2022 Oct 31;12:1032850. doi: 10.3389/fonc.2022.1032850. eCollection 2022.
6
Reduced Expression of Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated Up-Regulation.通过m6A甲基化介导的上调促进三阴性乳腺癌转移的[某种物质]表达降低 。 (注:原文中“Reduced Expression of ”这里缺少具体所指物质,翻译时根据语境添加了“[某种物质]”)
Front Oncol. 2020 Jul 14;10:1126. doi: 10.3389/fonc.2020.01126. eCollection 2020.
7
METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.METTL3 诱导的 miR-222-3p 上调抑制 STK4 并促进甲状腺癌细胞的恶性行为。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):474-490. doi: 10.1210/clinem/dgab480.
8
The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.m6A甲基转移酶METTL3通过MALAT1/miR-26b/HMGA2轴调控乳腺癌的上皮-间质转化、迁移和侵袭。
Cancer Cell Int. 2021 Aug 21;21(1):441. doi: 10.1186/s12935-021-02113-5.
9
Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.RNA N6-甲基腺苷甲基转移酶样 3 与 miR-186 之间的串扰通过 Wnt/β-catenin 信号通路调控肝癌进展。
Cell Prolif. 2020 Mar;53(3):e12768. doi: 10.1111/cpr.12768. Epub 2020 Jan 22.
10
Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.长链非编码 RNA Linc00339 通过 miR-377-3p/HOXC6 信号通路促进三阴性乳腺癌的进展。
J Cell Physiol. 2019 Aug;234(8):13303-13317. doi: 10.1002/jcp.28007. Epub 2019 Jan 7.

引用本文的文献

1
CircRNAs: a novel potential strategy to treat breast cancer.环状RNA:一种治疗乳腺癌的新型潜在策略。
Front Immunol. 2025 Mar 19;16:1563655. doi: 10.3389/fimmu.2025.1563655. eCollection 2025.
2
Regulation of mA (N-Methyladenosine) methylation modifiers in solid cancers.固体瘤中 mA(N6-甲基腺苷)甲基化修饰物的调控。
Funct Integr Genomics. 2024 Oct 23;24(6):193. doi: 10.1007/s10142-024-01467-z.
3
CircMETTL3-156aa reshapes the glycolytic metabolism of macrophages to promote M1 polarization and induce cytokine storms in sHLH.

本文引用的文献

1
Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer.YTHDF2 的抑制会触发 MYC 驱动型乳腺癌中的蛋白毒性细胞死亡。
Mol Cell. 2021 Aug 5;81(15):3048-3064.e9. doi: 10.1016/j.molcel.2021.06.014. Epub 2021 Jul 2.
2
A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.一个包含十个 N6-甲基腺苷相关的长非编码 RNA 的签名可以预测三阴性乳腺癌的预后。
J Clin Lab Anal. 2021 Jun;35(6):e23779. doi: 10.1002/jcla.23779. Epub 2021 May 2.
3
Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer.
环状METTL3-156aa重塑巨噬细胞的糖酵解代谢,以促进M1极化并在噬血细胞性淋巴组织细胞增生症中诱导细胞因子风暴。
Cell Death Discov. 2024 Oct 9;10(1):431. doi: 10.1038/s41420-024-02202-0.
4
Cross-talk between circRNAs and m6A modifications in solid tumors.环状 RNA 与实体瘤中 m6A 修饰的串扰。
J Transl Med. 2024 Jul 29;22(1):694. doi: 10.1186/s12967-024-05500-4.
5
Functions of methyltransferase-like 3 in breast cancer: pathogenesis, drug resistance, and therapeutic target.甲基转移酶样蛋白 3 在乳腺癌中的作用:发病机制、耐药性和治疗靶点。
Breast Cancer Res. 2024 Jul 3;26(1):110. doi: 10.1186/s13058-024-01869-8.
6
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy.靶向 RNA 修饰的药物治疗:癌症治疗的新前沿。
Cancer Med. 2024 Apr;13(7):e6989. doi: 10.1002/cam4.6989.
7
Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer.环状RNA介导的微小RNA海绵体及RNA结合蛋白在乳腺癌生物学调控中的作用
Noncoding RNA Res. 2024 Jan 3;9(1):262-276. doi: 10.1016/j.ncrna.2023.12.005. eCollection 2024 Mar.
8
Non-coding RNA-Mediated N6-Methyladenosine (mA) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response.非编码RNA介导的N6-甲基腺苷(m⁶A)沉积:癌症的关键调节因子,影响致癌作用和治疗反应中的关键信号通路。
Noncoding RNA Res. 2023 Nov 13;9(1):84-104. doi: 10.1016/j.ncrna.2023.11.005. eCollection 2024 Mar.
9
New insights into the regulation of METTL3 and its role in tumors.METTL3 调控及其在肿瘤中作用的新见解。
Cell Commun Signal. 2023 Nov 23;21(1):334. doi: 10.1186/s12964-023-01360-5.
10
Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer.非编码RNA与其他表观遗传修饰之间的相互作用在乳腺癌中的新作用
Front Oncol. 2023 Oct 12;13:1264090. doi: 10.3389/fonc.2023.1264090. eCollection 2023.
N6-甲基腺苷调节剂对三阴性乳腺癌进展和预后的影响。
Front Genet. 2021 Jan 28;11:580036. doi: 10.3389/fgene.2020.580036. eCollection 2020.
4
Neratinib in HER2-Positive Breast Cancer With Brain Metastases.来那替尼用于治疗HER2阳性且伴有脑转移的乳腺癌
J Clin Oncol. 2021 Jan 20;39(3):251-252. doi: 10.1200/JCO.20.02385. Epub 2020 Dec 17.
5
Adjuvant Capecitabine in Triple-Negative Breast Cancer: New Strategies for Tailoring Treatment Recommendations.三阴性乳腺癌的辅助性卡培他滨:调整治疗建议的新策略
JAMA. 2021 Jan 5;325(1):36-38. doi: 10.1001/jama.2020.23371.
6
Use of chemotherapy in elderly patients with early-stage triple-negative breast cancer.化疗在老年早期三阴性乳腺癌患者中的应用。
Lancet Oncol. 2020 Dec;21(12):1543-1545. doi: 10.1016/S1470-2045(20)30694-X.
7
Mitochondrial copper depletion suppresses triple-negative breast cancer in mice.线粒体铜耗竭抑制小鼠三阴性乳腺癌。
Nat Biotechnol. 2021 Mar;39(3):357-367. doi: 10.1038/s41587-020-0707-9. Epub 2020 Oct 19.
8
Multidisciplinary considerations in the treatment of triple-negative breast cancer.三阴性乳腺癌治疗中的多学科考量
CA Cancer J Clin. 2020 Nov;70(6):432-442. doi: 10.3322/caac.21643. Epub 2020 Sep 28.
9
Advancing immunotherapy for early-stage triple-negative breast cancer.推进早期三阴性乳腺癌的免疫治疗
Lancet. 2020 Oct 10;396(10257):1046-1048. doi: 10.1016/S0140-6736(20)31962-0. Epub 2020 Sep 20.
10
Reduced Expression of Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated Up-Regulation.通过m6A甲基化介导的上调促进三阴性乳腺癌转移的[某种物质]表达降低 。 (注:原文中“Reduced Expression of ”这里缺少具体所指物质,翻译时根据语境添加了“[某种物质]”)
Front Oncol. 2020 Jul 14;10:1126. doi: 10.3389/fonc.2020.01126. eCollection 2020.